Daily Multidrug Therapy for Leprosy; Results of a Fourteen-Year Experience

International Journal of Leprosy and Other Mycobacterial Diseases

Volumn 65, Issue 1, 1997, Pages 37-44

  De Carsalade, Georges Yves ^a   Wallach, Daniel ^a   Spindler, Edith ^a   Pennec, Jean ^a   Cottenot, Francois ^a   Flageul, Beatrice ^a  

^a SAINT LOUIS HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CLOFAZIMINE; DAPSONE; ETHIONAMIDE; RIFAMPICIN; SULFONE;

ADULT; ARTICLE; BACTERIAL GROWTH; CLINICAL ARTICLE; DRUG EFFICACY; DRUG SAFETY; FEMALE; GROWTH INHIBITION; HUMAN; LEPROSY; LEPROSY CONTROL; MALE; TREATMENT OUTCOME; WOUND HEALING;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; CLOFAZIMINE; DAPSONE; DRUG RESISTANCE, MICROBIAL; DRUG THERAPY, COMBINATION; ERYTHEMA NODOSUM; ETHIONAMIDE; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEPROSTATIC AGENTS; LEPROSY, BORDERLINE; LEPROSY, LEPROMATOUS; LEPROSY, TUBERCULOID; MALE; MIDDLE AGED; RECURRENCE; RIFAMPIN;

EID: 0030971037     PISSN: 0148916X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. BECX-BLEUMINK, M. and BERHE, D. Occurrence of reactions, their diagnosis and management in leprosy patients created with MDT; experience in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia. Int. J. Lepr. 60 (1992) 173-184.
2. BLOK, L. M., BLOOS, L. J. and VAN DEN BERG, G. A retrospective study of seven years of multiple drug treatment for paucibacillary and multibacillary leprosy in Bayara General Hospital, Nigeria. Lepr. Rev. 62 (1991) 193-200.
3. CHATTOPADHYAY, S. P., GUPTA, C. M., BHATE, R. D., BHATE, R. P. and SREEVASTA. Evaluation of two multidrug regimens in hospitalised multibacillary cases. Indian J. Lepr. 61 (1989) 196-205.
4. CHENG, Z.-Q., YANG, L.-H., FAN, D.-H. and HUANG, C.-Y. Results of skin smears from eightyfour MB patients on MDT MB regimen recommended by WHO. (Abstract) Int. J. Lepr. 61 (1993) 10A (CH 40).
5. DAY, R. S. and TETERISSA, M. R. Field trial of short course combined chemotherapy in paucibacillary leprosy. (Abstract) Int. J. Lepr. 57 Suppl. (1989) 340.
6. DE RIJK, A. J., GABRE, S., BYASS, P. and BERHANU, T. Field evaluation of WHO-MDT of fixed duration, at ALERT, Ethiopia: the AMFES project - II. Reaction and neuritis during and after MDT in PB and MB leprosy patients. Lepr. Rev. 65 (1994) 320-132.
7. FLAGEUL, B., VIGNON-PENNAMEN, M. D., WALLACH, D., PENNEC, J. and COTTENOT, F. Les reactions de reversion tardive au cours de la lepre. Acta Leprol. 7 (1990) 109-117.
8. GROENEN, G., JANSSENS, L., KAYEMBE, T., NOLLET, E., COUSSENS, L. and PATTYN, S. R. Prospective study on the relationship between intensive bactericidal therapy and leprosy reactions Int. J. Lepr. 56 (1986) 236-244.
9. GROSSET, J. H. Progress in the chemotherapy of leprosy. Int. J. Lepr. 62 (1994) 268-277.
10. KATOCH, K., RAMU, G., SENGUPTA, U., SREEVATSA, SHARMA, V. D., SHIVANNAVAR, C. T. and KATOCH, V. M. Results of a modified WHO regimen in highly bacilliferous BL/LL patients. Int. J. Lepr. 57 (1989) 451-457.
11. LIENHARDT, C. and FINE, P. E. M. Type 1 reaction neuritis and disability in leprosy. What is the current epidemiological situation? Lepr. Rev. 65 (1994) 9-33.
12. OREGE, P. A., OBURA, M., OKELO, C., OKUKU, P., NYAWLO, J. and MOKOKHA, S. Multidrug therapy for treatment of paucibacillary leprosy: the western Kenya experience. (Abstract) Int. J. Lepr. 57 Suppl. (1989) 341.
13. PANNIKAR, V., JESUDASAN, K., VIJAYAKUMARAN, P. and CHRISTIAN, M. Relapse or late reversal reaction. Int. J. Lepr. 57 (1989) 526-528.
14. RAMACHANDRAN, A. and SESHADRI, P. S. Relapse or reversal reaction: the case for a therapeutic trial of steroids. Lepr. Rev. 59 (1988) 271-272.
15. RAMANAN, R., MANGLANI, P. R., GHORPADE, A. and BHAGOLIWAL, S. K. Follow-up study of paucibacillary leprosy on multidrug regimen. Indian J. Lepr. 59 (1987) 50-53.
16. RAMU, G. Clinical features and diagnosis of relapses in leprosy. Indian J. Lepr. 67 (1995) 45-59.
17. RANGARAJ, M. and RANGARAJ, J. Experience with multidrug therapy in Sierra Leone: clinical, operational and managerial analysis. Lepr. Rev. 57 Suppl. (1985) 77-91.
18. RIDLEY, D. S. and JOPLING, W. J. Classification of leprosy according to immunity; a five-group system. Int. J. Lepr. 34 (1966) 255-273.
19. TIWARI, V. D., TUTAKNE, M. A., SINGH, G. and DUTTA, R. K. Multidrug therapy in hospitalised leprosy cases. Indian J. Lepr 60 (1988) 71-77.
20. VAN BRAKEL, W. H. and KHAWAS, I. B. Nerve damage in leprosy: an epidemiological and clinical study of 396 patients in west Nepal - part I. Definitions, methods and frequencies. Lepr. Rev. 65 (1994) 204-221.
21. VAN BRAKEL, W. H., KHAWAS, I. B. and LUCAS, S. B. Reactions in leprosy: an epidemiological study of 386 patients in west Nepal. Lepr Rev. 65 (1994) 190-203.
22. VIJAYAKUMARAN, P., MANIMOZHI, N. and JESUDASAN, K. Incidence of late lepra reaction among multibacillary patients after MDT. Int. J. Lepr. 63 (1995) 18-22.
23. WHO EXPERT COMMITTEE ON LEPROSY. Fourth report. Geneva: World Health Organization, 1970. Tech. Rep. Ser 495.
24. WHO STUDY GROUP. Chemotherapy of leprosy for control programmes. Geneva: World Health Organization, 1982. Tech. Rep. Ser. 675.
25. WHO STUDY GROUP. Chemotherapy of leprosy-Geneva: World Health Organization, 1994. Tech. Rep. Ser. 847.